Stock listing
BOATS:ATYR aTyr Pharma, Inc. Stock
US listing (BOATS) of aTyr Pharma, Inc. · home listing NASDAQ:ATYR
Follow aTyr Pharma, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ATYR
$6.29 USD +1.35 (+27.3%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ATYR
- Day range
- $5.03 – $6.42 USDNov 2, 2026
- Volume
- 335,951 sharesNov 2, 2026
- Market cap
- $18.87M USDAt the close on Nov 2, 2026 · price × 3.00M shares outstanding
- 52-week range
- $4.07 – $44.40 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $88,100 USDMedian day 663 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ATYR · Home | $6.29 USD | +1.35 (+27.3%) | 335,951 | $5.03 | $6.42 | $5.03 | $4.94 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ATYR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.29 | +1.35 | +27.3% | $5.03 | $6.42 | $5.03 | 335,951 | |
| $4.94 | -0.43 | -8.0% | $5.32 | $5.429 | $4.32 | 120,255 | |
| $5.37 | +0.234 | +4.6% | $4.83 | $5.60 | $4.81 | 229,673 | |
| $5.136 | +0.176 | +3.5% | $4.80 | $5.204 | $4.644 | 2,145 | |
| $4.96 | -1.176 | -19.2% | $4.868 | $5.10 | $4.068 | 5,348 | |
| $6.136 | -0.468 | -7.1% | $6.60 | $6.668 | $5.752 | 2,057 | |
| $6.604 | -0.196 | -2.9% | $6.812 | $6.88 | $6.40 | 813 | |
| $6.80 | -0.092 | -1.3% | $6.80 | $7.184 | $6.72 | 650 | |
| $6.892 | -0.04 | -0.6% | $6.92 | $7.188 | $6.824 | 772 | |
| $6.932 | +0.064 | +0.9% | $6.836 | $7.112 | $6.612 | 826 | |
| $6.868 | -0.092 | -1.3% | $7.196 | $7.36 | $6.60 | 1,319 | |
| $6.96 | -0.392 | -5.3% | $7.56 | $7.644 | $6.96 | 1,137 | |
| $7.352 | +0.02 | +0.3% | $7.60 | $7.88 | $7.352 | 1,391 | |
| $7.332 | -0.712 | -8.9% | $8.00 | $8.288 | $7.228 | 1,608 | |
| $8.044 | -0.548 | -6.4% | $8.80 | $8.80 | $8.00 | 1,654 | |
| $8.592 | -1.256 | -12.8% | $9.908 | $9.996 | $8.592 | 1,266 | |
| $9.848 | -0.364 | -3.6% | $10.21 | $10.36 | $9.84 | 625 | |
| $10.21 | -0.92 | -8.3% | $10.80 | $10.92 | $10.00 | 1,720 | |
| $11.13 | -0.204 | -1.8% | $11.16 | $11.55 | $10.88 | 701 | |
| $11.34 | -0.264 | -2.3% | $11.60 | $11.82 | $11.22 | 639 | |
| $11.60 | +0.112 | +1.0% | $11.33 | $11.76 | $10.60 | 1,131 | |
| $11.49 | -0.276 | -2.3% | $11.49 | $11.84 | $11.26 | 1,238 | |
| $11.76 | -0.356 | -2.9% | $12.20 | $12.41 | $11.60 | 1,372 | |
| $12.12 | -0.188 | -1.5% | $12.33 | $12.80 | $12.00 | 1,127 | |
| $12.31 | +0.40 | +3.4% | $11.67 | $12.72 | $10.88 | 2,408 | |
| $11.91 | -0.292 | -2.4% | $11.74 | $12.64 | $11.66 | 2,583 | |
| $12.20 | -1.304 | -9.7% | $12.37 | $12.66 | $11.28 | 5,225 | |
| $13.50 | -1.504 | -10.0% | $16.17 | $16.30 | $12.96 | 81,325 | |
| $15.01 | +0.752 | +5.3% | $14.40 | $15.20 | $14.00 | 749 | |
| $14.26 | -0.656 | -4.4% | $15.26 | $15.26 | $14.04 | 835 | |
| $14.91 | +0.392 | +2.7% | $15.20 | $15.20 | $14.74 | 574 | |
| $14.52 | -0.54 | -3.6% | $14.80 | $15.52 | $14.40 | 793 | |
| $15.06 | -0.304 | -2.0% | $15.80 | $15.92 | $14.80 | 628 | |
| $15.36 | -0.204 | -1.3% | $15.83 | $15.83 | $15.15 | 596 | |
| $15.57 | +0.024 | +0.2% | $15.76 | $16.03 | $15.00 | 663 | |
| $15.54 | -1.648 | -9.6% | $16.80 | $17.36 | $15.28 | 1,082 | |
| $17.19 | -0.084 | -0.5% | $17.42 | $17.86 | $16.87 | 891 | |
| $17.28 | -0.94 | -5.2% | $18.76 | $18.78 | $17.20 | 577 | |
| $18.22 | -1.016 | -5.3% | $19.20 | $19.44 | $18.02 | 519 | |
| $19.23 | -0.66 | -3.3% | $20.40 | $20.40 | $19.20 | 396 | |
| $19.89 | -0.248 | -1.2% | $19.60 | $20.32 | $19.49 | 159 | |
| $20.14 | +0.42 | +2.1% | $20.20 | $20.36 | $19.20 | 241 | |
| $19.72 | +0.66 | +3.5% | $19.28 | $20.36 | $19.28 | 438 | |
| $19.06 | -2.208 | -10.4% | $21.20 | $21.34 | $19.00 | 733 | |
| $21.27 | -0.332 | -1.5% | $21.60 | $21.72 | $20.04 | 640 | |
| $21.60 | -0.584 | -2.6% | $22.40 | $22.60 | $21.20 | 166 | |
| $22.18 | +0.144 | +0.7% | $22.48 | $22.48 | $21.78 | 184 | |
| $22.04 | -0.76 | -3.3% | $22.90 | $22.90 | $21.24 | 191 | |
| $22.80 | +1.60 | +7.5% | $21.54 | $22.80 | $21.29 | 423 | |
| $21.20 | +1.14 | +5.7% | $20.42 | $21.36 | $19.60 | 431 | |
| $20.06 | -0.06 | -0.3% | $20.40 | $21.36 | $20.01 | 327 | |
| $20.12 | -1.192 | -5.6% | $20.67 | $20.96 | $20.00 | 479 | |
| $21.31 | +1.148 | +5.7% | $20.46 | $21.50 | $20.11 | 375 | |
| $20.16 | -0.592 | -2.9% | $21.19 | $21.80 | $20.11 | 425 | |
| $20.76 | -1.604 | -7.2% | $21.64 | $22.80 | $20.72 | 391 | |
| $22.36 | +0.24 | +1.1% | $22.40 | $23.47 | $22.00 | 410 | |
| $22.12 | +0.508 | +2.4% | $22.00 | $24.00 | $21.74 | 794 | |
| $21.61 | +0.252 | +1.2% | $21.76 | $22.28 | $21.01 | 207 | |
| $21.36 | +0.204 | +1.0% | $21.60 | $21.68 | $20.56 | 310 | |
| $21.16 | +0.70 | +3.4% | $21.38 | $21.52 | $20.22 | 382 | |
| $20.46 | +0.376 | +1.9% | $19.86 | $20.80 | $19.86 | 231 | |
| $20.08 | -1.08 | -5.1% | $21.16 | $21.16 | $19.60 | 364 | |
| $21.16 | -0.008 | 0.0% | $21.17 | $21.20 | $20.12 | 286 | |
| $21.17 | +1.488 | +7.6% | $20.40 | $21.40 | $20.22 | 609 | |
| $19.68 | +0.252 | +1.3% | $19.71 | $20.40 | $19.20 | 484 |
- Ticker
- BOATS:ATYR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
Latest deck · Jun 1, 2026
Investor Presentation (June 2026)
Investor deck · 27 slides
Latest news
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
Oct 29, 2026
Closed $5.37 (+4.6%) on Oct 29, 2026
aTyr Pharma Announces One-for-40 Reverse Stock Split
Oct 27, 2026
Closed $4.96 (-19.2%) on Oct 27, 2026
aTyr Pharma Announces Research Collaboration with Montefiore Einstein
Oct 19, 2026
Closed $6.87 (-1.3%) on Oct 19, 2026
aTyr Pharma Announces Publication Demonstrating Anti-Fibrotic Effects of ATYR0101 in the Journal of Biological Chemistry
Oct 13, 2026
Closed $8.04 (-6.4%) on Oct 13, 2026
ATyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
Sep 24, 2026
Closed $13.50 (-10.0%) on Sep 24, 2026
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
Sep 1, 2026
Closed $19.72 (+3.5%) on Sep 2, 2026
ATyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
Aug 10, 2026
Closed $21.16 (+3.4%) on Aug 10, 2026
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
Jul 15, 2026
Closed $21.37 (+9.9%) on Jul 15, 2026
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
May 15, 2026
Closed $20.16 (-10.0%) on May 15, 2026
aTyr Pharma to Participate in Upcoming Investor Conferences
May 13, 2026
Closed $22.40 (+41.4%) on May 14, 2026
Decks
Investor Presentation (June 2026)
Investor deck · 27 slides · Jun 1, 2026
Corporate Update (May 2026)
Corporate update · 12 slides · May 11, 2026
Technical Presentation (September 2025)
Technical · 11 slides · Sep 15, 2025
European Respiratory Society (ERS) Congress 2025
Conference · 15 slides · September 2025
aTyr Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 167 in all · newest Oct 29, 2026 · oldest 2019
- Decks
- 24 decks · latest Jun 1, 2026
Where aTyr Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ATYR · Home listing | NASDAQ | United States | USD |
| gettex:471A | gettex | Germany | EUR |
| Tradegate:471A | Tradegate | Germany | EUR |
| LS Exchange:A2PM86 | LS Exchange | Germany | EUR |
| BOATS:ATYR · This page | BOATS | United States | USD |
| Lang & Schwarz:A2PM86 | Lang & Schwarz | Germany | EUR |
| Frankfurt:471A | Frankfurt | Germany | EUR |
| Hamburg:471A | Hamburg | Germany | EUR |
| Munich:471A | Munich | Germany | EUR |
| Dusseldorf:471A | Dusseldorf | Germany | EUR |
| Stuttgart:471A | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about aTyr Pharma, Inc.